Screener
Diebold Nixdorf DBD Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 25.2%+0.6pp | 25.2%+0.5pp | 25.3%+0.7pp | 24.7%+1.0pp | 24.6%+1.0pp | |
| Operating margin | 6.4%+1.6pp | 6.4%+1.3pp | 6.4%+1.5pp | 5.4%+0.1pp | 4.7%+1.5pp | |
| Net margin | 2.9%— | 2.8%— | 2.5%— | —— | —— | |
| Returns | ||||||
| Return on equity | 10.8%— | 10.8%— | 9.3%— | —— | —— | |
| Return on invested capital | 10.2%+3.1pp | 11.4%+3.4pp | 11.1%+3.1pp | 11.5%-4.5pp | 7.1%— | |
| Efficiency | ||||||
| Asset turnover | 1×+0.1× | 1×+0.1× | 1×+0.1× | 1×-0.1× | 1×-0.6× | |
| Liquidity | ||||||
| Current ratio | 1.3×-0.1× | 1.3×-0.1× | 1.3×0.0× | 1.4×-0.1× | 1.4×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 1×+0.1× | 1×-0.1× | 1×-0.1× | 0.9×+0.9× | 0.9×+0.9× | |
| Net debt / EBITDA | 1.9×-0.7× | 1.6×-1.6× | 2×-1.4× | 2.4×+3.4× | 2.6×+3.8× | |
| Per Share | ||||||
| Book value per share | $27.46-6.2% | $28.65+9.5% | $29.57+19.6% | $29.92+5.5% | $29.26+10.7% | |
| Valuation | ||||||
| Market capitalization | $2.14B+2.3% | $2.65B+61.3% | $2.44B+50.6% | $2.09B+24.4% | $2B+38.3% | |
| Price / earnings | 19.3×— | 24.6×— | 25.7×— | —— | —— | |
| Price / sales | 0.6×0.0× | 0.7×+0.2× | 0.6×+0.2× | 0.6×+0.2× | 0.5×+0.3× | |
| Price / book | 2.2×+0.3× | 2.6×+0.9× | 2.2×+0.5× | 1.9×+0.3× | 1.8×+0.4× | |
| EV / EBITDA | 7.7×-1.4× | 8.4×-1.9× | 8.5×-2.1× | 9.1×+4.8× | 10.2×+6.4× |
FAQ
- What are Diebold Nixdorf's profit margins?
- Diebold Nixdorf (DBD) runs a 25.2% gross margin and a 6.4% operating margin, with a 2.9% net margin.
- Where do Diebold Nixdorf's ratios come from?
- Every ratio is computed from Diebold Nixdorf's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
